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Research into the effectiveness of epilepsy specialist nursing needs to take into account a number of factors, which have not
been adequately addressed in previous studies. Nursing outcome measures are different to medical ones and it is inappropriate
to confuse these. Specialist nurses affect the whole culture of a service, and their impact on service quality may go beyond that
of their individual patient contacts. Thus randomized studies within a service that already has specialist nurses may not give
valid results. Some service users will benefit more from direct contact with a specialist nurse than others, and people who give
informed consent to take part in randomized controlled trials might not be representative of those who would benefit most from
specialist nurse access. The stampede for level one evidence risks failing to address the issues properly by overvaluing research
process (form) against its appropriateness (content), yet there remain great opportunities for good quality research in this area.
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It has been pointed out elsewhere in this issue1 that
it is inappropriate to use ‘medical’ outcome measures
such as seizure frequency as the main criteria for
evaluating nursing interventions, and that use should
be made of nursing-based outcomes instead. Although
it is obviously incorrect to draw conclusions from
studies that use the wrong outcome measures, it seems
this point has not been sufficiently addressed in the
evaluation of research. The recent Cochrane Review2
could be given as an example. However, there are other
aspects of research design that have also not been
adequately addressed up to the present.
It is generally accepted that nurses starting in newly
created epilepsy specialist nurse posts take a while to
develop the most effective ways of working. It takes
time to acquire office space, information technology
and educational resources. Something else that takes
time but is crucial to the epilepsy specialist nurse role
is the development of a certain degree of personal
networking within the organization, and also beyond
it, for example in primary care or with local social
care and educational establishments. At the recent
Liverpool ILAE conference the view was expressed
that such a process may take up to year. It is therefore
inappropriate to start a clinical trial on day one of a
nurse specialist’s appointment in a newly created post,
although this apparently happened in one randomized
controlled trial (RCT). The value of such a study
must be extremely limited, and adds very little to the
body of knowledge about epilepsy specialist nursing.
However, in the stampede for acquiring a certain type
of ‘evidence’ a perverse regard is given to such work
purely on the basis that it was an RCT.
I would like to suggest that research effort take
into account three underlying assumptions. They are
of course themselves susceptible to challenge and to
study.
(1) Specialist nurses affect the whole culture of a
service, and their impact on service quality
may go beyond that of their individual
patient contact.
Those who work with specialist nurses note
that the training of non-specialist nurses and
of other professions in primary care teams
and in social care situations is strengthened.
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Some doctors’ time is freed up for other things
that the doctors might not otherwise do. If
new service users are randomized to ‘nurse’
or ‘no nurse’ within a service that already has
a specialist nurse service, then the ‘no nurse’
group will still be seen in a service that has a
specialist nurse service. This may well reduce
differences between groups. A further problem
is that many epilepsy units that have specialist
nurses operate an open access policy whereby
people with epilepsy are encouraged to self-
refer. People randomized to ‘no nurse’ in such
situations would have nothing to prevent them
making contact directly. How to deal with these
statistically is a challenge (see below).
(2) Some service users will benefit more from
direct contact with a specialist nurse than
others, and
(3) People who give informed consent to take
part in RCTs might not be representative of
those who would benefit most from specialist
nurse access.
Service users eligible for inclusion in an
ethically conducted trial would have the role of
the epilepsy specialist nurse explained to them.
They might then be asked, ‘will you consent to
enter a clinical trial in which you have a 50%
chance of seeing a specialist nurse and a 50%
chance of not seeing one?’ They would also
have to be told that if they didn’t enter the trial
they would have a 100% chance of seeing a
specialist nurse if they wished. One might argue
that people who felt they might need to see a
nurse would be less likely to agree to enter a
study. On the other hand, people who felt it
didn’t matter much whether they saw a nurse
or not would be more likely to agree to enter,
having nothing to lose. Furthermore, people
who feel they might benefit from direct contact
with a specialist nurse might indeed be more
likely to do so than those who are indifferent.
Such self-selection for inclusion in clinical trials
would therefore tend to distort outcomes by
minimizing differences between the groups.
A more appropriate way of conducting a RCT would
be to take two complete services, one of which had
epilepsy specialist nurses and one that did not, and
randomize new patients between them. There would
still be some blurring of boundaries if the specialist
nurses took part in training of residential care staff
in the community and staff in primary care settings,
as this might have an impact on subjects allocated to
the control ‘no-nurse’ group. But, even if two such
services could be found covering the same catchment
area, there would still be the issue of what sort of
people would give informed consent to participate.
In this case, the question would be, ‘do you wish to
take part in a study where you have a 50% chance of
being allocated to a service where there are nursing
staff trained in the subject who have specialist skills
in dealing with your problems, and a 50% chance of
being allocated to a service where the nursing staff
do not have these skills?’ This is really a rhetorical
question, although the answer might depend on what
alternatives are available for people who do not take
part in the study. One way of boosting recruitment
would be to have the service that has specialist nursing
in it only available to people taking part in the trial and
randomized to it. There are clearly serious resource
problems in setting up such a trial. Since no such trial
has been carried out I would suggest that there is no
suitable evidence at the RCT level of the effectiveness
or not of epilepsy specialist nurses.
I was once involved in a failed attempt to partially
address some of these issues. There was an epilepsy
service (based in what we might call hospital A)
with well-established specialist nurses with an open-
access self-referral policy in addition to direct referral
from medical practitioners. The specialist nurses did
not see all people with epilepsy, but anyone who
so wished could make contact. Referrals to nurses
from medical practitioners came from both within
and without the epilepsy service. The nurses also
played an important role in training care staff in
residential homes, and in working to improve the skills
of primary care staff in the community. In the next
town there was a district general hospital (B) served
by the same neurology team, with similar access
to electroencephalogram (EEG), computerized tomo-
grapy (CT), and magnetic resonance imaging (MRI),
but with no epilepsy specialist nurses. Catchment area
demographics were similar for hospitals A and B. The
only obvious differences between the two services
were that one had specialist nurses and the other did
not, and that they were in different towns. Although
we could not randomize new referrals to one or
other service, I thought there might nevertheless be
value in a parallel group design taking equivalent
cohorts of new patients recruited in the same time
period, and follow them up using a variety of
appropriate measures. There would still be some
potential contamination of the ‘non-nurse’ hospital
B group for three main reasons. Firstly, with A’s
open access policy, some patients from B nevertheless
found their way to A’s specialist nurses. Secondly,
some GPs in hospital B’s catchment area used the
services of the nurses in hospital A, and thirdly,
paediatric and general medical consultants in hospital
B sometimes circumvented the neurology service by
directly referring to A’s specialist nurses. In order to
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know how to deal with these ‘crossover’ patients in
the statistical analysis, I consulted with a specialist
in evidence-based medicine and trial design. The
whole concept that I outlined was, I was told, of
no value because there was no randomization. Only
randomization would do. Randomization is king.
Because of the geographical distance between A and
B and the difficulty of travelling for patients, we
obviously couldn’t take all referrals to both hospitals
and randomly allocate between the two. Instead, the
only reasonable way forward was to drop hospital
B completely and randomly allocate people referred
to hospital A to see, or not to see, the specialist
nurse. I pointed out that not everyone needed referral
to specialist nurses. Easy, came the reply, randomize
to ‘see nurse if you want to’ vs. ‘don’t see nurse’.
But, I said, we have an open access policy; some
people randomized to ‘no-nurse’ might still see the
nurses of their own accord. Also, usual treatment
would mean having nurse access. The trial wouldn’t be
one investigating the potential value of a new service
component that would otherwise not be available, it
would be one of the effect of cutting out a bit of
the service already available. Surely that would raise
ethical, let alone recruitment, problems? In that case,
I was told, people randomized to ‘no-nurse’ group
could of course make contact with a nurse if they
wished but for statistical reasons they would have
to be treated as if they had not seen a nurse, on
the basis of intention-to-treat analysis. After speaking
to the expert, therefore, the best design for an
RCT evaluating the effectiveness of specialist nursing
meant that people could be randomized to one of two
groups. In the first group they could see a specialist
nurse if they wanted to, but didn’t have to. In the
second group they didn’t have to see a nurse unless
they wanted to. It seemed obvious to me (but not
to the expert) that these two intervention packages
were essentially identical, and yet apparently if there
were no real differences between outcomes in the two
groups, this would suggest epilepsy specialist nursing
had nothing special to offer. The study of course
never got done. I was left musing on the triumph
of form over content. An RCT was just the thing
because it was an RCT and for no other reason. This
took precedence over the use of appropriate subjects,
intervention packages and outcome measures. As
Nigel Molesworth is reported to have said, ‘Ebm-ers
swank much about there hierarky of evidens, from
meta-analysis at top to anecdot at bottom, and say
Your study is below RCT, so is No Good chiz3’.
We also lack solid evidence for the value or
effectiveness of doctors in epilepsy teams, certainly
at the RCT level. There are however, interesting
reports from non-randomized studies showing that
appropriately trained health workers who are not
doctors can diagnose and treat many people with
epilepsy4–6. Suppose we were to use the same rules
for evaluating the role of doctors as has been applied to
the value of specialist nurses? We might well be drawn
towards a negative or at best equivocal, conclusion.
Could we justify advising health commissioners of the
value of increasing the establishment of neurologists?
Alternatively we could come to our senses. All that
is being proposed is that professionals who work in a
specialist service have training in, and develop skills
in, that specialism. There is a rich seam to be mined
in investigating the effectiveness of various cadres
of the service in carrying out the different service
tasks (diagnosis, management of drug regimes, and
counseling and other therapies). If we wanted to take
it up, there is an opportunity to do something useful.
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